CATH Superfamily 2.60.120.970
The name of this superfamily has been modified since the most recent official CATH+ release (v4_4_0). At the point of the last release, this superfamily was: waiting to be named.
FunFam 8: Bone morphogenetic protein 7
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 7 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
24 |
A8K571 (/IPI)
A8K571 (/IPI)
A8K571 (/IPI)
A8K571 (/IPI)
A8K571 (/IPI)
A8K571 (/IPI)
A8K571 (/IPI)
A8K571 (/IPI)
A8K571 (/IPI)
A8K571 (/IPI)
(14 more) |
Cytokine activity GO:0005125
Functions to control the survival, growth, differentiation and effector function of tissues and cells.
|
2 | P23359 (/TAS) P23359 (/TAS) |
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
2 | G3V6W8 (/IDA) G3V6W8 (/IDA) |
Heparin binding GO:0008201
Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
|
2 | F1Q926 (/IDA) Q9PTF9 (/IDA) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
2 | F1Q926 (/IPI) Q9PTF9 (/IPI) |
BMP receptor binding GO:0070700
Interacting selectively and non-covalently with a BMP receptor.
|
2 | P23359 (/ISO) P23359 (/ISO) |
There are 158 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
13 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(3 more) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
13 |
F1Q926 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
(3 more) |
Ureteric bud development GO:0001657
The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
|
12 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(2 more) |
Mesenchyme development GO:0060485
The process whose specific outcome is the progression of a mesenchymal tissue over time, from its formation to the mature structure. A mesenchymal tissue is made up of loosely packed stellate cells.
|
12 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(2 more) |
Skeletal system development GO:0001501
The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
|
11 |
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
(1 more) |
Metanephros development GO:0001656
The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine.
|
11 |
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
(1 more) |
Mesonephros development GO:0001823
The process whose specific outcome is the progression of the mesonephros over time, from its formation to the mature structure. In mammals, the mesonephros is the second of the three embryonic kidneys to be established and exists only transiently. In lower vertebrates such as fish and amphibia, the mesonephros will form the mature kidney.
|
11 |
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
P18075 (/IEP)
(1 more) |
Epithelial to mesenchymal transition GO:0001837
A transition where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
11 |
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
(1 more) |
Endocardial cushion formation GO:0003272
The developmental process pertaining to the initial formation of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Pericardium morphogenesis GO:0003344
The process in which the anatomical structure of the pericardium is generated and organized.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Negative regulation of striated muscle cell apoptotic process GO:0010664
Any process that decreases the rate or extent of striated muscle cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a striated muscle cell and result in its death.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
11 |
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
(1 more) |
Dendrite development GO:0016358
The process whose specific outcome is the progression of the dendrite over time, from its formation to the mature structure.
|
11 |
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
(1 more) |
Neural fold elevation formation GO:0021502
The process in which the lateral borders of the neural plate begin to migrate upwards to form the neural folds, caused by the proliferation of the underlying mesoderm.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Hindbrain development GO:0030902
The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium).
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Negative regulation of NF-kappaB transcription factor activity GO:0032088
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Protein localization to nucleus GO:0034504
A process in which a protein transports or maintains the localization of another protein to the nucleus.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Negative regulation of phosphorylation GO:0042326
Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Steroid hormone mediated signaling pathway GO:0043401
A series of molecular signals mediated by a steroid hormone binding to a receptor.
|
11 |
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
(1 more) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Negative regulation of neuron differentiation GO:0045665
Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Negative regulation of mitotic nuclear division GO:0045839
Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Cardiac muscle tissue development GO:0048738
The process whose specific outcome is the progression of cardiac muscle over time, from its formation to the mature structure.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Mesenchymal cell differentiation GO:0048762
The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Neuron projection morphogenesis GO:0048812
The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Pharyngeal system development GO:0060037
The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Regulation of pathway-restricted SMAD protein phosphorylation GO:0060393
Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Cardiac septum morphogenesis GO:0060411
The process in which the anatomical structure of a cardiac septum is generated and organized. A cardiac septum is a partition that separates parts of the heart.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Chorio-allantoic fusion GO:0060710
The cell-cell adhesion process in which the cells of the chorion fuse to the cells of the allantois.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Heart trabecula morphogenesis GO:0061384
The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Monocyte aggregation GO:0070487
The adhesion of one monocyte to one or more other monocytes via adhesion molecules.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
11 |
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
P18075 (/IMP)
(1 more) |
Negative regulation of glomerular mesangial cell proliferation GO:0072125
Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Positive regulation of dendrite development GO:1900006
Any process that activates or increases the frequency, rate or extent of dendrite development.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Positive regulation of hyaluranon cable assembly GO:1900106
Any process that activates or increases the frequency, rate or extent of hyaluranon cable assembly.
|
11 |
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(1 more) |
Negative regulation of NIK/NF-kappaB signaling GO:1901223
Any process that stops, prevents or reduces the frequency, rate or extent of NIK/NF-kappaB signaling.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Allantois development GO:1905069
The process whose specific outcome is the progression of an allantois over time, from its formation to the mature structure.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Regulation of removal of superoxide radicals GO:2000121
Any process that modulates the frequency, rate or extent of removal of superoxide radicals.
|
11 |
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
P18075 (/ISS)
(1 more) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
Protein localization to nucleus GO:0034504
A process in which a protein transports or maintains the localization of another protein to the nucleus.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
Negative regulation of phosphorylation GO:0042326
Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
Negative regulation of mitotic nuclear division GO:0045839
Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
Mesenchymal cell differentiation GO:0048762
The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
Negative regulation of glomerular mesangial cell proliferation GO:0072125
Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation.
|
3 | P23359 (/ISS) P23359 (/ISS) P34819 (/ISS) |
Eye development GO:0001654
The process whose specific outcome is the progression of the eye over time, from its formation to the mature structure. The eye is the organ of sight.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Ureteric bud development GO:0001657
The process whose specific outcome is the progression of the ureteric bud over time, from its formation to the mature structure.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Mesoderm formation GO:0001707
The process that gives rise to the mesoderm. This process pertains to the initial formation of the structure from unspecified parts.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Kidney development GO:0001822
The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Heart looping GO:0001947
The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Embryonic heart tube morphogenesis GO:0003143
The process in which the anatomical structures of the embryonic heart tube are generated and organized. The embryonic heart tube is an epithelial tube that will give rise to the mature heart.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Endocardial cushion formation GO:0003272
The developmental process pertaining to the initial formation of an endocardial cushion. The endocardial cushion is a specialized region of mesenchymal cells that will give rise to the heart septa and valves.
|
2 | P23359 (/IGI) P23359 (/IGI) |
BMP signaling pathway involved in heart jogging GO:0003303
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, which contributes to the process of heart jogging.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Pericardium morphogenesis GO:0003344
The process in which the anatomical structure of the pericardium is generated and organized.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Determination of left/right symmetry GO:0007368
The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Pattern specification process GO:0007389
Any developmental process that results in the creation of defined areas or spaces within an organism to which cells respond and eventually are instructed to differentiate.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Axon guidance GO:0007411
The chemotaxis process that directs the migration of an axon growth cone to a specific target site in response to a combination of attractive and repulsive cues.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Salivary gland morphogenesis GO:0007435
The process in which the anatomical structures of the salivary gland are generated and organized.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Negative regulation of cell population proliferation GO:0008285
Any process that stops, prevents or reduces the rate or extent of cell proliferation.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Embryonic pattern specification GO:0009880
The process that results in the patterns of cell differentiation that will arise in an embryo.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Animal organ morphogenesis GO:0009887
Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
2 | F1Q926 (/IEP) Q9PTF9 (/IEP) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
2 | F1Q926 (/IGI) Q9PTF9 (/IGI) |
Dorsal/ventral pattern formation GO:0009953
The regionalization process in which the areas along the dorsal/ventral axis are established that will lead to differences in cell differentiation. The dorsal/ventral axis is defined by a line that runs orthogonal to both the anterior/posterior and left/right axes. The dorsal end is defined by the upper or back side of an organism. The ventral end is defined by the lower or front side of an organism.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Positive regulation of gene expression GO:0010628
Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product or products (proteins or RNA). This includes the production of an RNA transcript as well as any processing to produce a mature RNA product or an mRNA or circRNA (for protein-coding genes) and the translation of that mRNA or circRNA into protein. Protein maturation is included when required to form an active form of a product from an inactive precursor form.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Positive regulation of epithelial to mesenchymal transition GO:0010718
Any process that increases the rate, frequency, or extent of epithelial to mesenchymal transition. Epithelial to mesenchymal transition is where an epithelial cell loses apical/basolateral polarity, severs intercellular adhesive junctions, degrades basement membrane components and becomes a migratory mesenchymal cell.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Positive regulation of peptidyl-threonine phosphorylation GO:0010800
Any process that increases the frequency, rate or extent of peptidyl-threonine phosphorylation. Peptidyl-threonine phosphorylation is the phosphorylation of peptidyl-threonine to form peptidyl-O-phospho-L-threonine.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862
Any process that increases the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Positive regulation of cell death GO:0010942
Any process that increases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Neural fold elevation formation GO:0021502
The process in which the lateral borders of the neural plate begin to migrate upwards to form the neural folds, caused by the proliferation of the underlying mesoderm.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Locus ceruleus development GO:0021703
The process whose specific outcome is the progression of the locus ceruleus over time, from its formation to the mature structure. The locus ceruleus is a dense cluster of neurons within the dorsorostral pons. This nucleus is the major location of neurons that release norepinephrine throughout the brain, and is responsible for physiological responses to stress and panic.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Embryonic limb morphogenesis GO:0030326
The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Positive regulation of bone mineralization GO:0030501
Any process that activates or increases the frequency, rate or extent of bone mineralization.
|
2 | P23359 (/ISO) P23359 (/ISO) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | P23359 (/ISO) P23359 (/ISO) |
BMP signaling pathway GO:0030509
A series of molecular signals initiated by the binding of a member of the BMP (bone morphogenetic protein) family to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
2 | G3V6W8 (/TAS) G3V6W8 (/TAS) |
Epithelial cell differentiation GO:0030855
The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Hindbrain development GO:0030902
The process whose specific outcome is the progression of the hindbrain over time, from its formation to the mature structure. The hindbrain is the posterior of the three primary divisions of the developing chordate brain, or the corresponding part of the adult brain (in vertebrates, includes the cerebellum, pons, and medulla oblongata and controls the autonomic functions and equilibrium).
|
2 | P23359 (/IGI) P23359 (/IGI) |
Response to estradiol GO:0032355
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
|
2 | G3V6W8 (/IEP) G3V6W8 (/IEP) |
Response to vitamin D GO:0033280
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a vitamin D stimulus.
|
2 | G3V6W8 (/IEP) G3V6W8 (/IEP) |
Positive regulation of heterotypic cell-cell adhesion GO:0034116
Any process that activates or increases the frequency, rate, or extent of heterotypic cell-cell adhesion.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Protein localization to nucleus GO:0034504
A process in which a protein transports or maintains the localization of another protein to the nucleus.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Tube morphogenesis GO:0035239
The process in which the anatomical structures of a tube are generated and organized. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Post-anal tail morphogenesis GO:0036342
The process in which a post-anal tail is generated and organized. A post-anal tail is a muscular region of the body that extends posterior to the anus. The post-anal tail may aid locomotion and balance.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Regulation of phosphorylation GO:0042325
Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule.
|
2 | G3V6W8 (/IMP) G3V6W8 (/IMP) |
Regulation of phosphorylation GO:0042325
Any process that modulates the frequency, rate or extent of addition of phosphate groups into a molecule.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Negative regulation of phosphorylation GO:0042326
Any process that stops, prevents or decreases the rate of addition of phosphate groups to a molecule.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Odontogenesis of dentin-containing tooth GO:0042475
The process whose specific outcome is the progression of a dentin-containing tooth over time, from its formation to the mature structure. A dentin-containing tooth is a hard, bony organ borne on the jaw or other bone of a vertebrate, and is composed mainly of dentin, a dense calcified substance, covered by a layer of enamel.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Negative regulation of endodermal cell fate specification GO:0042664
Any process that restricts, stops or prevents a cell from specifying into an endoderm cell.
|
2 | F1Q926 (/IGI) Q9PTF9 (/IGI) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Steroid hormone mediated signaling pathway GO:0043401
A series of molecular signals mediated by a steroid hormone binding to a receptor.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Negative regulation of MAP kinase activity GO:0043407
Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Response to peptide hormone GO:0043434
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
|
2 | G3V6W8 (/IEP) G3V6W8 (/IEP) |
Positive regulation of cell differentiation GO:0045597
Any process that activates or increases the frequency, rate or extent of cell differentiation.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Negative regulation of neuron differentiation GO:0045665
Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Negative regulation of neuron differentiation GO:0045665
Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Positive regulation of neuron differentiation GO:0045666
Any process that activates or increases the frequency, rate or extent of neuron differentiation.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Positive regulation of osteoblast differentiation GO:0045669
Any process that activates or increases the frequency, rate or extent of osteoblast differentiation.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Negative regulation of Notch signaling pathway GO:0045746
Any process that stops, prevents, or reduces the frequency, rate or extent of the Notch signaling pathway.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Negative regulation of cell cycle GO:0045786
Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Negative regulation of mitotic nuclear division GO:0045839
Any process that stops, prevents or reduces the rate or extent of mitosis. Mitosis is the division of the eukaryotic cell nucleus to produce two daughter nuclei that, usually, contain the identical chromosome complement to their mother.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Negative regulation of transcription, DNA-templated GO:0045892
Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Positive regulation of transcription by RNA polymerase II GO:0045944
Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
2 | F1Q926 (/IDA) Q9PTF9 (/IDA) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
2 | F1Q926 (/IGI) Q9PTF9 (/IGI) |
Determination of ventral identity GO:0048264
The regionalization process that results in the determination of the identity of part of an organism or organ where those parts are of the type that occur in the ventral region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Cell development GO:0048468
The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Camera-type eye morphogenesis GO:0048593
The process in which the anatomical structures of the eye are generated and organized. The camera-type eye is an organ of sight that receives light through an aperture and focuses it through a lens, projecting it on a photoreceptor field.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Embryonic camera-type eye morphogenesis GO:0048596
The process in which the anatomical structures of the eye are generated and organized during embryonic development.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Anatomical structure formation involved in morphogenesis GO:0048646
The developmental process pertaining to the initial formation of an anatomical structure from unspecified parts. This process begins with the specific processes that contribute to the appearance of the discrete structure and ends when the structural rudiment is recognizable. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Cardiac muscle tissue development GO:0048738
The process whose specific outcome is the progression of cardiac muscle over time, from its formation to the mature structure.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Branching morphogenesis of an epithelial tube GO:0048754
The process in which the anatomical structures of branches in an epithelial tube are generated and organized. A tube is a long hollow cylinder.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Mesenchymal cell differentiation GO:0048762
The process in which a relatively unspecialized cell acquires specialized features of a mesenchymal cell. A mesenchymal cell is a loosely associated cell that is part of the connective tissue in an organism. Mesenchymal cells give rise to more mature connective tissue cell types.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Neuron projection morphogenesis GO:0048812
The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Neuron projection morphogenesis GO:0048812
The process in which the anatomical structures of a neuron projection are generated and organized. A neuron projection is any process extending from a neural cell, such as axons or dendrites.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Negative regulation of neurogenesis GO:0050768
Any process that stops, prevents, or reduces the frequency, rate or extent of neurogenesis, the generation of cells within the nervous system.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Pharyngeal system development GO:0060037
The process whose specific outcome is the progression of the pharyngeal system over time, from its formation to the mature structure. The pharyngeal system is a transient embryonic complex that is specific to vertebrates. It comprises the pharyngeal arches, bulges of tissues of mesoderm and neural crest derivation through which pass nerves and pharyngeal arch arteries. The arches are separated internally by pharyngeal pouches, evaginations of foregut endoderm, and externally by pharyngeal clefts, invaginations of surface ectoderm. The development of the system ends when the stucture it contributes to are forming: the thymus, thyroid, parathyroids, maxilla, mandible, aortic arch, cardiac outflow tract, external and middle ear.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Embryonic skeletal joint morphogenesis GO:0060272
The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Embryonic skeletal joint morphogenesis GO:0060272
The process in which the anatomical structures of skeletal joints are generated and organized during the embryonic phase. A skeletal joint is the connecting structure between the bones of the skeleton.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Regulation of pathway-restricted SMAD protein phosphorylation GO:0060393
Any process that modulates the rate, frequency or extent of pathway-restricted SMAD protein phosphorylation. Pathway-restricted SMAD proteins and common-partner SMAD proteins are involved in the transforming growth factor beta receptor signaling pathways.
|
2 | P23359 (/ISO) P23359 (/ISO) |
SMAD protein signal transduction GO:0060395
The cascade of processes by which a signal interacts with a receptor, causing a change in the activity of a SMAD protein, and ultimately effecting a change in the functioning of the cell.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Cardiac septum morphogenesis GO:0060411
The process in which the anatomical structure of a cardiac septum is generated and organized. A cardiac septum is a partition that separates parts of the heart.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Branching involved in salivary gland morphogenesis GO:0060445
The process in which the branching structure of the salivary gland is generated and organized.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Mesenchyme development GO:0060485
The process whose specific outcome is the progression of a mesenchymal tissue over time, from its formation to the mature structure. A mesenchymal tissue is made up of loosely packed stellate cells.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Negative regulation of prostatic bud formation GO:0060686
Any process that decreases the rate, frequency, or extent of prostatic bud formation, the morphogenetic process in which a region of the fetal urogenital sinus epithelium is specified to become the prostate, resulting in prostate bud outgrowth.
|
2 | P23359 (/IDA) P23359 (/IDA) |
Regulation of branching involved in prostate gland morphogenesis GO:0060687
Any process that modulates the rate, frequency, or extent of prostate gland branching, the process in which the branching structure of the prostate gland is generated and organized. A branch is a division or offshoot from a main stem.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Chorio-allantoic fusion GO:0060710
The cell-cell adhesion process in which the cells of the chorion fuse to the cells of the allantois.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Heart trabecula morphogenesis GO:0061384
The process of shaping a trabecula in the heart. A trabecula is a small, often microscopic, tissue element in the form of a small beam, strut or rod, which generally has a mechanical function. Trabecula are usually but not necessarily, composed of dense collagenous tissue.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Protein-containing complex assembly GO:0065003
The aggregation, arrangement and bonding together of a set of macromolecules to form a protein-containing complex.
|
2 | F1Q926 (/IMP) Q9PTF9 (/IMP) |
Monocyte aggregation GO:0070487
The adhesion of one monocyte to one or more other monocytes via adhesion molecules.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Cellular response to BMP stimulus GO:0071773
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a bone morphogenetic protein (BMP) stimulus.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis GO:0072040
Any process that reduces the occurrence or rate of mesenchymal stem cell death by apoptotic process that contributes to the shaping of the nephron.
|
2 | P23359 (/IMP) P23359 (/IMP) |
Negative regulation of glomerular mesangial cell proliferation GO:0072125
Any process that decreases the frequency, rate or extent of glomerular mesangial cell proliferation.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Metanephric mesenchyme morphogenesis GO:0072133
The process in which the anatomical structures of a metanephric mesenchymal tissue are generated and organized. Metanephric mesenchyme is the tissue made up of loosely connected mesenchymal cells in the metanephros.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Nephrogenic mesenchyme morphogenesis GO:0072134
The process in which the anatomical structures of a nephrogenic mesenchymal tissue are generated and organized. Nephrogenic mesenchyme is the tissue made up of loosely connected mesenchymal cells in the nephron.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Metanephric mesenchymal cell proliferation involved in metanephros development GO:0072136
The multiplication or reproduction of cells, resulting in the expansion of a metanephric mesenchymal cell population.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Positive regulation of dendrite development GO:1900006
Any process that activates or increases the frequency, rate or extent of dendrite development.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Positive regulation of hyaluranon cable assembly GO:1900106
Any process that activates or increases the frequency, rate or extent of hyaluranon cable assembly.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Allantois development GO:1905069
The process whose specific outcome is the progression of an allantois over time, from its formation to the mature structure.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis GO:1905312
Any process that activates or increases the frequency, rate or extent of cardiac neural crest cell migration involved in outflow tract morphogenesis.
|
2 | P23359 (/IGI) P23359 (/IGI) |
Positive regulation of progesterone secretion GO:2000872
Any process that activates or increases the frequency, rate or extent of progesterone secretion.
|
2 | F1NUT2 (/TAS) Q9I8T6 (/TAS) |
Negative regulation of cell death GO:0060548
Any process that decreases the rate or frequency of cell death. Cell death is the specific activation or halting of processes within a cell so that its vital functions markedly cease, rather than simply deteriorating gradually over time, which culminates in cell death.
|
1 | P34819 (/ISS) |
There are 7 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
15 |
G3V6W8 (/IDA)
G3V6W8 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
P18075 (/IDA)
(5 more) |
Extracellular region GO:0005576
The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
|
11 |
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
P18075 (/TAS)
(1 more) |
Extracellular space GO:0005615
That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Vesicle GO:0031982
Any small, fluid-filled, spherical organelle enclosed by membrane.
|
2 | G3V6W8 (/IDA) G3V6W8 (/IDA) |
Vesicle GO:0031982
Any small, fluid-filled, spherical organelle enclosed by membrane.
|
2 | P23359 (/ISO) P23359 (/ISO) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
2 | G3V6W8 (/IDA) G3V6W8 (/IDA) |
Collagen-containing extracellular matrix GO:0062023
An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells.
|
2 | P23359 (/ISO) P23359 (/ISO) |